Delivery Order SPE2DB20D1100-SPE2DB25FD2W8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,128.85 to AmerisourceBergen Drug Corp for the supply of Sunosi 150 mg tablets (30-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Sunosi 150 mg tablets (30-count packaging) valued at $1,013.56. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion master agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on July 17, 2025, for the supply of Sunosi 75 mg tablets (30-count units) with a ceiling value of $4,264.03. This non-set-aside contract represents a firm fixed price delivery order and is part of AmerisourceBergen's broader engagement with DLA's medical supply chain. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 18,...
- The Defense Logistics Agency awarded a $1,881.03 delivery order to AmerisourceBergen Drug Corp for Sunosi 75 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Sunosi 150 mg tablets (30-count units) valued at $21,491.34 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is expected to be completed by September 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $2,721.90 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Sunosi 75 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 19, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,335.06 on August 6, 2025, for the supply of Sunosi 150 mg tablets (30-count). This is a firm fixed-price, non-set-aside contract with performance through August 7, 2025, to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $2,445.76 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count). This firm fixed-price contract represents a non-set-aside competitive award and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,792.60 to AmerisourceBergen Drug Corp for the supply of Sunosi (solriamfetol) 75 mg tablets in a 30-count package. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, and the place of...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Sunosi 75 mg tablets (30-count packages) valued at $1,344.45. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The contract is scheduled for ultimate completion on September 19, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD2W8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,141.29 to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Sunosi 150 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is scheduled for ultimate completion on July 9, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Sunosi is a wakefulness-promoting agent used in military and federal healthcare systems to address fatigue-related conditions, and this specific order reflects the routine pharmaceutical fulfillment activities conducted under the larger strategic vehicle that supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/8/25 |